News
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...
Merck is looking to strengthen its respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer ...
Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...
When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...
Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.
3d
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product ...
Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
This $117 billion Australian success story asked the US government to give it a break on tariffs, but is now waiting to see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results